Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05986604 · ClinicalTrials.gov registry record · NA

NIA_Improving Function and Well-being by Improving Patient Memory: Transdiagnostic Sleep and Circadian Treatment

A NA study of Sleep Disorder and Memory Impairment, sponsored by University of California, Berkeley.

Recruiting
Registry status
NA
Development phase
178
Enrollment target
1
Study location

NCT05986604: Recruiting NA study of Sleep Disorder and Memory Impairment, sponsored by University of California, Berkeley.

NCT05986604 is a NA study of Sleep Disorder and Memory Impairment that is actively recruiting participants, run by University of California, Berkeley. The registered enrollment target is 178 participants, above the 154-participant average among 22 other Sleep Disorder trials with a reported enrollment target (16% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05986604, a NA study of Sleep Disorder and Memory Impairment, is actively recruiting participants, sponsored by University of California, Berkeley.

RECRUITING
Registry status
NA
Development phase
178 participants
Enrollment target
1
Study location

Study Summary

Mental illness is often chronic, severe, and difficult to treat. Though there has been significant progress towards establishing effective and efficient interventions for psychological health problems, many individuals do not gain lasting benefits from these treatments. The Memory Support Intervention (MSI) was developed utilizing existing findings from the cognitive science literature to improve treatment outcomes. In this study, the investigators aim to conduct an open trial that includes individuals 50 years and older to assess if a novel version of the Memory Support Intervention improves sleep and circadian functioning, reduces functional impairment, and improves patient memory for treatment.

Primary Outcome

Assesses perceived functional impairments related to sleep problems using a self-report questionnaire. The minimum value is 8. The maximum value is 40. Higher scores mean more sleep disturbance (worse outcome).

Conditions Studied

Sleep Disorder Memory Impairment Circadian Dysregulation

Interventions

  • BEHAVIORAL Memory Support Intervention
  • BEHAVIORAL Transdiagnostic Intervention for Sleep and Circadian Dysfunction

Study Locations (1)

California

  • University of California, Berkeley - Berkeley

Trial Details

FieldValue
Enrollment Target 178 participants
Start Date 2024-01-04
Est. Completion 2028-07-28
Phase NA
University of California, Berkeley

72 total trials

What NCT05986604 shows while recruiting

NCT05986604 is an interventional study that assigns participants to a tested intervention. The registered 178 participants enrollment target is mid-sized for trials with a published cap, above the 154-participant average among 22 other Sleep Disorder trials with a reported enrollment target (16% higher).

The record links to 3 conditions, with Sleep Disorder appearing as the primary indexed condition, and to 2 interventions - of which Memory Support Intervention is the first listed.

NCT05986604 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05986604 about?

NCT05986604 is a clinical study titled "NIA_Improving Function and Well-being by Improving Patient Memory: Transdiagnostic Sleep and Circadian Treatment". Mental illness is often chronic, severe, and difficult to treat. Though there has been significant progress towards establishing effective and efficient interventions for psychological health problems, many individuals do not gain lasting benefits from these treatments. The Memory Support Interventi...

What is the current status of trial NCT05986604?

This trial is currently recruiting. It is a NA study. The enrollment target is 178 participants. The study started on 2024-01-04. Estimated completion is 2028-07-28.

What conditions does trial NCT05986604 study?

This clinical trial studies the following conditions: Sleep Disorder, Memory Impairment, Circadian Dysregulation.

What interventions are being tested in trial NCT05986604?

The interventions under investigation include: Memory Support Intervention (BEHAVIORAL), Transdiagnostic Intervention for Sleep and Circadian Dysfunction (BEHAVIORAL).

Who is sponsoring clinical trial NCT05986604?

This trial is sponsored by University of California, Berkeley, which has 72 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05986604 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Sleep Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05986604's enrollment target sits among peer trials

178 9th of 22 higher than 14 of 22 other Sleep Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sleep Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03642002 · 178 participants · NA

    The Effects of Music Therapy on Adult Patients Requiring Mechanical Ventilation in the ICU

  • NCT04227847 · 178 participants · Phase 1

    A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies

  • NCT04855214 · 178 participants

    Evaluating the Experience of Upper Limb Prosthesis Use

  • NCT05391126 · 178 participants · NA

    GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT05986604

Source: ClinicalTrials.gov NCT05986604, the US trial registry maintained by the National Library of Medicine. NCT05986604 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.